WELLS FARGO & COMPANY/MN - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 50 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2024$65
-92.4%
50
-91.0%
0.00%
Q1 2024$854
+56.7%
558
+20.0%
0.00%
Q4 2023$545
+42.3%
465
+5.4%
0.00%
Q3 2023$383
-20.0%
441
+3.0%
0.00%
Q2 2023$479
+14.0%
428
+5.9%
0.00%
Q1 2023$420
-5.8%
404
+1.5%
0.00%
Q4 2022$446398
+2.3%
0.00%
Q3 2022$0389
+0.3%
0.00%
Q2 2022$0388
+676.0%
0.00%
Q1 2022$050
-2.0%
0.00%
Q4 2021$0
-100.0%
51
-85.7%
0.00%
Q3 2021$2,0000.0%356
-4.3%
0.00%
Q2 2021$2,000
+100.0%
372
+25.7%
0.00%
Q1 2021$1,0000.0%296
+8.0%
0.00%
Q4 2020$1,000
-98.5%
274
-99.4%
0.00%
Q3 2020$66,000
-22.4%
42,527
-6.1%
0.00%
Q2 2020$85,00045,305
+17258.2%
0.00%
Q1 2020$0
-100.0%
261
-80.3%
0.00%
Q2 2019$1,000
-94.4%
1,327
-89.6%
0.00%
Q1 2019$18,000
+28.6%
12,703
-0.3%
0.00%
Q4 2018$14,000
-83.3%
12,742
-6.3%
0.00%
Q3 2018$84,000
-34.4%
13,597
+13.3%
0.00%
Q2 2018$128,000
-7.2%
12,004
-6.4%
0.00%
Q1 2018$138,000
+53.3%
12,829
+0.3%
0.00%
Q4 2017$90,000
-43.4%
12,792
-29.6%
0.00%
Q3 2017$159,000
+4.6%
18,180
+8.6%
0.00%
Q2 2017$152,000
+14.3%
16,7390.0%0.00%
Q1 2017$133,000
+280.0%
16,739
+325.0%
0.00%
Q4 2016$35,0003,9390.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2024
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,458,600$5,630,0005.96%
Carmignac Gestion 2,485,652$5,692,0000.09%
XTX Topco Ltd 50,947$117,0000.05%
Golden State Equity Partners 31,327$72,0000.04%
GSA CAPITAL PARTNERS LLP 78,274$179,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$725,0000.01%
Newman Dignan & Sheerar, Inc. 27,023$62,0000.01%
Curi Wealth Management, LLC 25,000$57,0000.01%
Northeast Financial Consultants Inc 53,000$121,0000.01%
Assenagon Asset Management S.A. 913,789$2,093,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders